The presence of chronic kidney disease (CKD) has been suggested to elicit early onset reductions in lean body mass leading to disease related sarcopenia 1 and poor functional performance. We investigated the prevalence of sarcopenia in a Scottish cohort receiving long term (>6 months) haemodialysis and its association with age, dialysis vintage, comorbidity and inflammation.
Binomial logistic regression revealed the presence of sarcopenia to be associated with age (p < 0·01) and Charlson co-morbidity index (p < 0·05), but not with length of time patients had been receiving dialysis (vintage) or hsCRP.
These results indicate a high prevalence of secondary disease related sarcopenia in a relatively young dialysis population. In this cohort, the presence of secondary sarcopenia was associated with age and comorbidities but not with the presence of inflammation or dialysis vintage. These results also suggest that anthropometric markers of muscle mass are unlikely to be sufficiently sensitive to diagnosis sarcopenia. The results require confirmation in a larger more diverse population, but suggest that work is required to identify targeted interventions which can halt or prevent the development of secondary disease related sarcopenia in this group.
